Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Cypherpunk Technologies Inc., 3 years.
Cypherpunk Technologies Inc.
Director
AN2 Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Cypherpunk Technologies Inc. | Open-market sale | −50,000 | $3.86 | $193,000 |
| Jul 10, 2026 | AN2 Therapeutics Inc. | Grant or award | +766 | — | — |
| Apr 10, 2026 | AN2 Therapeutics Inc. | Grant or award | +1,192 | — | — |
| Mar 13, 2026 | Cypherpunk Technologies Inc. | Option exercise | +74,700 | — | — |
| Mar 13, 2026 | Cypherpunk Technologies Inc. | Option exercise | +94,050 | — | — |
| Jan 12, 2026 | AN2 Therapeutics Inc. | Grant or award | +3,650 | — | — |
| Oct 10, 2025 | AN2 Therapeutics Inc. | Grant or award | +3,274 | — | — |
| Jul 10, 2025 | AN2 Therapeutics Inc. | Grant or award | +3,750 | — | — |
| Apr 10, 2025 | AN2 Therapeutics Inc. | Grant or award | +3,065 | — | — |
| Dec 19, 2024 | AN2 Therapeutics Inc. | Grant or award | +3,166 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.